Omnicell (NASDAQ: OMCL) reported Q2 EPS of $0.84, $0.02 worse than the analyst estimate of $0.86. Revenue for the quarter came in at $331 million versus the consensus estimate of $339.74 million.

GUIDANCE:

Omnicell maintains FY2022 EPS of $3.85-$4.05. Omnicell maintains FY2022 revenue of $1.385-1.41 million, versus the consensus of $1.4 million.

For earnings history and earnings-related data on Omnicell (OMCL) click here.